These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 32386228)

  • 1. Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia.
    Yuill S; Egger S; Smith M; Velentzis L; Wrede CD; Bateson D; Canfell K
    J Infect Dis; 2020 Jul; 222(3):499-508. PubMed ID: 32386228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has the human papillomavirus (HPV) immunization programme improved obstetric outcomes in spontaneous delivery? An ecological study.
    Xu X; Woolner A; Bhattacharya S; Cotton S; Zhao F; Cruickshank M
    Eur J Obstet Gynecol Reprod Biol; 2021 Jul; 262():221-227. PubMed ID: 34082145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
    Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
    Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis.
    Wang A; Liu C; Wang Y; Yin A; Wu J; Zhang C; Luo M; Du L; Xiong Y; Zhao X; Huang Y
    Hum Vaccin Immunother; 2020 Mar; 16(3):581-589. PubMed ID: 31486334
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes.
    Yuill S; Velentzis LS; Smith M; Egger S; Wrede CD; Bateson D; Arbyn M; Canfell K
    Hum Vaccin Immunother; 2021 Oct; 17(10):3562-3576. PubMed ID: 34506257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey.
    Brotherton JM; Liu B; Donovan B; Kaldor JM; Saville M
    Vaccine; 2014 Jan; 32(5):592-7. PubMed ID: 24316239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous preterm birth risk among HPV-vaccinated and -unvaccinated women: a nationwide retrospective cohort study of over 240 000 singleton births.
    McClymont E; Faber MT; Belmonte F; Kjaer SK
    BJOG; 2023 Mar; 130(4):358-365. PubMed ID: 36424904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
    Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
    Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial.
    Kalliala I; Eriksson T; Aro K; Hokkanen M; Lehtinen M; Gissler M; Nieminen P
    Prev Med; 2021 May; 146():106473. PubMed ID: 33639181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.
    Bukowinski AT; Hall C; Chang RN; Gumbs GR; Marie S Conlin A
    Vaccine; 2020 Aug; 38(37):5933-5939. PubMed ID: 32712082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between influenza vaccination during pregnancy and adverse birth outcomes.
    Zerbo O; Modaressi S; Chan B; Goddard K; Lewis N; Bok K; Fireman B; Klein NP; Baxter R
    Vaccine; 2017 May; 35(24):3186-3190. PubMed ID: 28483192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
    Fotheringham P; Safi N; Li Z; Anazodo A; Remond M; Hayen A; Currow D; Roder D; Hamad N; Nicholl M; Gordon A; Frawley J; Sullivan EA
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):729-739. PubMed ID: 36915236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
    Faber MT; Duun-Henriksen AK; Dehlendorff C; Tatla MK; Munk C; Kjaer SK
    Vaccine; 2019 Jan; 37(2):265-271. PubMed ID: 30503078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.
    Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K
    Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.
    McHugh L; Marshall HS; Perrett KP; Nolan T; Wood N; Lambert SB; Richmond P; Ware RS; Binks P; Binks MJ; Andrews RM
    Clin Infect Dis; 2019 Jan; 68(3):402-408. PubMed ID: 30475988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.
    Lipkind HS; Vazquez-Benitez G; Nordin JD; Romitti PA; Naleway AL; Klein NP; Hechter RC; Jackson ML; Hambidge SJ; Lee GM; Sukumaran L; Kharbanda EO
    Obstet Gynecol; 2017 Sep; 130(3):599-608. PubMed ID: 28796684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcomes in Aboriginal mother-infant pairs from the Northern Territory, Australia, who received 23-valent polysaccharide pneumococcal vaccination during pregnancy, 2006-2011: The PneuMum randomised controlled trial.
    McHugh L; Binks M; Ware RS; Snelling T; Nelson S; Nelson J; Dunbar M; Mulholland EK; Andrews RM
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):82-87. PubMed ID: 31198999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
    Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
    Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
    Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.